ABL Bio Inc Cash Flow Quality Index

Latest as of June 2025: 0.96x

ABL Bio Inc cash flow quality index. ABL Bio Inc (298380) has a Cash Flow Quality Index of 0.96x as of June 2025. Operating cash flow of ₩38.30 Billion is below net income of ₩39.78 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 298380 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

0.96x
Operating CF / Net Income

Operating Cash Flow

₩38.30 Billion
KRW

Net Income

₩39.78 Billion
KRW

Data as of

Jun 2025
Most recent filing

Cash Flow Quality Index of ABL Bio Inc (2022–2022)

Cash flow quality index of ABL Bio Inc from 2022 to 2022. Historical Cash Flow Quality Index for ABL Bio Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. See ABL Bio Inc balance sheet independence to measure how much of total assets are equity-financed.

ABL Bio Inc Cash Flow Quality Index by Year (2022–2022)

ABL Bio Inc cash flow quality index by year from 2022 to 2022. Year-by-year earnings quality comparison for ABL Bio Inc. For the full cash flow conversion analysis, see cash flow conversion of ABL Bio Inc.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2022 22.48x ₩72.13 Billion ₩3.21 Billion —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.